NCS 613 significantly inhibited 70 to 98% of LPS-induced TNFα production from PBLs originated from SLE patients (SLE1, P = 0.008; SLE2, P = 0.005; SLE3, P = 0.0002). The gene discussed is TNF; the disease is systemic lupus erythematosus.